Moreover, EZH2 overexpression can mitigate AAA progression by increasing H3K27me3 levels at annexin A6 (ANXA6) promoter, reducing ROS levels and VSMC senescence induced by Ang II (Li et al., 2022). The gene discussed is EZH2; the disease is triple-A syndrome.